The observed dysfunctions due to PPARγ loss were restored once transgenic mice received AT1R blockers, providing evidence that AT1R contributes to the endothelial dysfunction induced by PPARγ inhibition [41]. This evidence concerns the gene AGTR1 and endothelial dysfunction.